Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.

Source:http://linkedlifedata.com/resource/pubmed/id/18419389

Download in:

View as

General Info

PMID
18419389